Unibest
← Back to patent-cliff list

CAS 93635-76-8

(2S,3R)-ethyl 3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate

Codes: SOFO-020

Application context (from source-drug indications)

Hepatitis CSofosbuvir/VelpatasvirChronic hepatitis CSofosbuvir/VelpatasvirEnd-stage renal diseaseSofosbuvir/VelpatasvirLiver transplant rejectionSofosbuvir/VelpatasvirKidney transplant rejectionSofosbuvir/VelpatasvirHeart failureSofosbuvir/VelpatasvirChronic hepatitis CSofosbuvirHepatitis CSofosbuvirChronic hepatitis BSofosbuvirHepatitis E virus infectionSofosbuvirLiver cirrhosisSofosbuvirPortal hypertensionSofosbuvir

Source drugs (routes using this intermediate)

DrugTierExpiry
Sofosbuvir/VelpatasvirTier B — Position early-
SofosbuvirTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Taizhou GMP-like Site2'-Deoxy-2'-fluoro-2'- Methyl-N-(phenylcarbonyl) cytidine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works2'-deoxy-2'-fluoro-2'-C-methyluridine
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.